bezafibrate has been researched along with Adrenoleukodystrophy in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Dijkstra, IM; Kemp, S; Ofman, R; Schackmann, MJ; Wanders, RJ | 1 |
| Dijkstra, IM; Engelen, M; Fourcade, S; Houten, SM; Kemp, S; Ofman, R; Poll-The, BT; Pujol, A; Sanders, RJ; Schackmann, MJ; Wanders, RJ | 1 |
| Brennecke, J; Dijkstra, IM; Engelen, M; Kemp, S; Moser, AB; Ofman, R; Poll-The, BT; Tran, L; Wanders, RJ | 1 |
1 trial(s) available for bezafibrate and Adrenoleukodystrophy
| Article | Year |
|---|---|
Bezafibrate for X-linked adrenoleukodystrophy.
Topics: Adrenoleukodystrophy; Bezafibrate; Humans; Hypolipidemic Agents; Male; Treatment Outcome | 2012 |
2 other study(ies) available for bezafibrate and Adrenoleukodystrophy
| Article | Year |
|---|---|
Enzymatic characterization of ELOVL1, a key enzyme in very long-chain fatty acid synthesis.
Topics: Acetyltransferases; Adrenoleukodystrophy; Bezafibrate; Enzyme Inhibitors; Fatty Acid Elongases; Fatty Acids; Fibroblasts; Gemfibrozil; HEK293 Cells; Humans; Hypolipidemic Agents; Kinetics; Microsomes; Transfection | 2015 |
Bezafibrate lowers very long-chain fatty acids in X-linked adrenoleukodystrophy fibroblasts by inhibiting fatty acid elongation.
Topics: Acetyltransferases; Adrenoleukodystrophy; Animals; ATP Binding Cassette Transporter, Subfamily D, Member 1; ATP-Binding Cassette Transporters; Bezafibrate; Cells, Cultured; Enzyme Inhibitors; Fatty Acid Elongases; Fatty Acids; Humans; Hypolipidemic Agents; Male; Mice; Mice, Transgenic; Microsomes, Liver; Oxidation-Reduction; Peroxisome Proliferator-Activated Receptors; Recombinant Proteins | 2012 |